Laurence W. Lytton 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:48 pm Sale | 2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Laurence W. Lytton | 11,900 0.100% | -113,129 (-90.48%) | Filing |
| 2023-02-13 4:03 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Laurence W. Lytton | 125,029 8.400% | -477 (-0.38%) | Filing |
| 2022-11-23 1:01 pm Purchase | 2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP | Laurence W. Lytton | 125,506 8.800% | 125,506 (New Position) | Filing |